Alternating recombinant and natural alpha-interferon helps to prevent clinical resistance to interferon in cutaneous T-cell lymphoma treatment [12] (multiple letters)

Acta Dermato-Venereologica

Volumn 78, Issue 2, 1998, Pages 159-

  Altomare, G ^a   Capella, G L ^a   Frigerio, E ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETINATE; INTERFERON; RECOMBINANT ALPHA INTERFERON;

ADULT; AGED; CLINICAL ARTICLE; DRUG RESISTANCE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LETTER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 17544386421     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155598433638     Document Type: Letter

References (0)